Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

This study has been completed.

Sponsor:

Collaborators:

Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site)

Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study)

University of Stellenbosch

HJ-CTC George, RSA (Statistics & Report)

Information provided by (Responsible Party):

Vakzine Projekt Management GmbH

ClinicalTrials.gov Identifier:

NCT01113281

First received: April 27, 2010

Last updated: November 18, 2011

Last verified: November 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2011
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)